Comparing telegenetics and in-person genetic counselling
Official title: Telegenetics or In-Person Genetic Counselling: A Comparison of Clinical Outcomes and Cost
Run by National Cancer Centre, Singapore · NCT04738708 · Data updated 2026-11-12
This study is testing whether online genetic counseling is just as good and cost-effective as in-person counseling for patients considering genetic tests for hereditary breast and ovarian cancer and Lynch syndrome.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | National Cancer Centre, Singapore Academic / other |
| Locations | 1 site (Singapore) |
| Status | Recruiting |
| Started | February 1, 2021 |
| Main results expected | October 6, 2026 |
| Study ends | October 6, 2026 |
| Registry record updated | April 28, 2026 |
| Trial ID | NCT04738708 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 21 and older who are referred for pre-test genetic counselling for HBOC or Lynch syndrome.
✕Probably not a fit
Patients who require urgent genetic results or have cognitive impairments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study compares the clinical outcomes and costs associated with telegenetics versus in-person genetic counselling for patients considering germline testing for hereditary breast and ovarian cancer (HBOC) and Lynch syndrome. It aims to evaluate patient-reported outcomes, including informed choice and psychosocial impacts, to determine if telegenetics is a feasible and effective alternative to traditional counselling methods. The study will recruit 150 patients at the National Cancer Centre Singapore, where participants will complete questionnaires assessing their experiences and outcomes after their consultations.
Why it matters
Potential benefit: If successful, this study could provide a more accessible and cost-effective model for genetic counselling services.
How similar studies have gone: Other studies have shown promising results for telegenetics, indicating it may be a viable alternative to in-person counselling.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 21 years old. * Patients referred to CGS at NCCS for HBOC or Lynch syndrome pre-test genetic counselling. * Able to read and understand the English Language. * Able to consent and agree to be randomized to either telegenetics or in-person genetic counselling. Exclusion Criteria: * Under the age of 21 years old. * Patients who require genetic results urgently. * Cognitive difficulty/ impairment or current psychiatric or physical illness (visual/ hearing/ neurological) which impairs sound judgement and accurate reporting of medical history over video consultation.
Where it's running
-
National Cancer Centre Singapore
Singapore, Singapore Recruiting
Study contacts
- Principal investigator: Ryan Tan — National Cancer Centre, Singapore
- Study coordinator: Ryan Tan
- Email: ryan.shea.tan.y.c@singhealth.com.sg
- Phone: +65 6436 8000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Germline genetic profiling for targeted prostate cancer screening and treatment
This study is testing if targeted prostate cancer screening can help men who are at higher genetic risk due to their family history or ethnicity find cancer earlier and improve their treatment options.
-
AI chatbot to screen for hereditary cancer risk in Singaporeans
A chat-based AI tool is being tested to see if it can quickly and reliably flag people who may have hereditary cancer risk.
-
CCC model to help serious illness conversations and care in cancer
This trial tests a Communication and Care Coordinator (CCC) model to see if it can improve communication about serious illness and care planning for cancer patients.
-
Histotripsy treatment for small liver tumours in Asia
This trial will try using histotripsy, a noninvasive focused-ultrasound treatment, to destroy small liver tumors in adults in Asia who are not candidates for surgery or other local therapies.
-
Aromatherapy for Mild Cognitive Impairment and Mild Dementia
This study tests whether a diffused essential-oil blend for 6 months can help reduce symptoms for people with MCI or mild dementia and lessen caregiver stress.
-
Exercise plus cognitive behavioural therapy for fatigue in women treated for breast cancer in Singapore
This program tests whether graded exercise combined with cognitive behavioural therapy can reduce fatigue and help women with breast cancer stay on their treatment plans.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.